ASX - By Stock
|
1AD |
BIO24: So that's a wrap
|
|
waynesworld
|
0 |
61 |
0 |
08:18 |
08:18 |
ASX - By Stock
|
0
|
61
|
0
|
|
ASX - By Stock
|
PER |
Re:
Ann: Percheron appoints Dr Cathryn Clary as Chief Medical Advisor
|
|
waynesworld
|
127 |
31K |
15 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
127
|
31K
|
15
|
|
ASX - By Stock
|
PER |
Re:
Ann: Percheron appoints Dr Cathryn Clary as Chief Medical Advisor
|
|
waynesworld
|
127 |
31K |
4 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
127
|
31K
|
4
|
|
ASX - By Stock
|
PER |
Re:
Ann: Percheron appoints Dr Cathryn Clary as Chief Medical Advisor
|
|
waynesworld
|
127 |
31K |
31 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
127
|
31K
|
31
|
|
ASX - By Stock
|
PER |
Re:
Clean insights and information easily found
|
|
waynesworld
|
122 |
25K |
21 |
02/06/24 |
02/06/24 |
ASX - By Stock
|
122
|
25K
|
21
|
|
ASX - By Stock
|
PER |
Re:
Clean insights and information easily found
|
|
waynesworld
|
122 |
25K |
25 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
122
|
25K
|
25
|
|
ASX - By Stock
|
PER |
Re:
Ann: Phase IIb study of ATL1102 in DMD completes recruitment
|
|
waynesworld
|
102 |
25K |
35 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
102
|
25K
|
35
|
|
ASX - By Stock
|
1AD |
Re:
Ann: SYNThesis BioVentures MoU for cellular immunotherapies
|
|
waynesworld
|
126 |
27K |
3 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
126
|
27K
|
3
|
|
ASX - By Stock
|
1AD |
Re:
Ann: SYNThesis BioVentures MoU for cellular immunotherapies
|
|
waynesworld
|
126 |
27K |
6 |
19/05/24 |
19/05/24 |
ASX - By Stock
|
126
|
27K
|
6
|
|
ASX - By Stock
|
1AD |
Re:
Ann: Positive AD-214 Phase I extension study results
|
|
waynesworld
|
262 |
54K |
5 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
262
|
54K
|
5
|
|
ASX - By Stock
|
1AD |
Re:
Ann: Positive AD-214 Phase I extension study results
|
|
waynesworld
|
262 |
54K |
13 |
24/03/24 |
24/03/24 |
ASX - By Stock
|
262
|
54K
|
13
|
|
ASX - By Stock
|
PER |
Re:
PER - Megathread
|
|
waynesworld
|
326 |
102K |
35 |
17/03/24 |
17/03/24 |
ASX - By Stock
|
326
|
102K
|
35
|
|
ASX - By Stock
|
PER |
Re:
PER - Megathread
|
|
waynesworld
|
326 |
102K |
23 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
326
|
102K
|
23
|
|
ASX - By Stock
|
PER |
Re:
PER - Megathread
|
|
waynesworld
|
326 |
102K |
19 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
326
|
102K
|
19
|
|
ASX - By Stock
|
PER |
Re:
PER - Megathread
|
|
waynesworld
|
326 |
102K |
24 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
326
|
102K
|
24
|
|
ASX - By Stock
|
PER |
Re:
PER - Megathread
|
|
waynesworld
|
326 |
102K |
7 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
326
|
102K
|
7
|
|
ASX - By Stock
|
PER |
Re:
PER - Megathread
|
|
waynesworld
|
326 |
102K |
28 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
326
|
102K
|
28
|
|
ASX - By Stock
|
PER |
Re:
PER - Megathread
|
|
waynesworld
|
326 |
102K |
50 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
326
|
102K
|
50
|
|
ASX - By Stock
|
ARR Mining |
Re:
Spotlight on American Rare Earths
|
|
waynesworld
|
4.3K |
1.4M |
11 |
02/03/24 |
02/03/24 |
ASX - By Stock
|
4.3K
|
1.4M
|
11
|
|
ASX - By Stock
|
ARR Mining |
Re:
Spotlight on American Rare Earths
|
|
waynesworld
|
4.3K |
1.4M |
12 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
4.3K
|
1.4M
|
12
|
|
ASX - By Stock
|
ARR Mining |
Re:
Spotlight on American Rare Earths
|
|
waynesworld
|
4.3K |
1.4M |
16 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
4.3K
|
1.4M
|
16
|
|
ASX - By Stock
|
ARR Mining |
Re:
Spotlight on American Rare Earths
|
|
waynesworld
|
4.3K |
1.4M |
9 |
25/02/24 |
25/02/24 |
ASX - By Stock
|
4.3K
|
1.4M
|
9
|
|
ASX - By Stock
|
ARR Mining |
Re:
Spotlight on American Rare Earths
|
|
waynesworld
|
4.3K |
1.4M |
21 |
20/02/24 |
20/02/24 |
ASX - By Stock
|
4.3K
|
1.4M
|
21
|
|
ASX - By Stock
|
ARR Mining |
Re:
Spotlight on American Rare Earths
|
|
waynesworld
|
4.3K |
1.4M |
7 |
19/02/24 |
19/02/24 |
ASX - By Stock
|
4.3K
|
1.4M
|
7
|
|
ASX - By Stock
|
ARR Mining |
Re:
Spotlight on American Rare Earths
|
|
waynesworld
|
4.3K |
1.4M |
15 |
18/02/24 |
18/02/24 |
ASX - By Stock
|
4.3K
|
1.4M
|
15
|
|
ASX - By Stock
|
ARR Mining |
Re:
Spotlight on American Rare Earths
|
|
waynesworld
|
4.3K |
1.4M |
24 |
17/02/24 |
17/02/24 |
ASX - By Stock
|
4.3K
|
1.4M
|
24
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
waynesworld
|
24K |
11M |
47 |
03/02/24 |
03/02/24 |
ASX - By Stock
|
24K
|
11M
|
47
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
waynesworld
|
24K |
11M |
48 |
02/02/24 |
02/02/24 |
ASX - By Stock
|
24K
|
11M
|
48
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
waynesworld
|
24K |
11M |
27 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
24K
|
11M
|
27
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
waynesworld
|
24K |
11M |
38 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
24K
|
11M
|
38
|
|
ASX - By Stock
|
IMU |
Re:
Ann: VAXINIA Phase 1 trial doses patients in higher dose cohorts
|
|
waynesworld
|
126 |
53K |
47 |
21/01/24 |
21/01/24 |
ASX - By Stock
|
126
|
53K
|
47
|
|
ASX - By Stock
|
IMU |
Re:
Ann: VAXINIA Phase 1 trial doses patients in higher dose cohorts
|
|
waynesworld
|
126 |
53K |
54 |
20/01/24 |
20/01/24 |
ASX - By Stock
|
126
|
53K
|
54
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Phase 2 Stroke Clinical Trial Update
|
|
waynesworld
|
64 |
22K |
10 |
21/12/23 |
21/12/23 |
ASX - By Stock
|
64
|
22K
|
10
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
waynesworld
|
24K |
11M |
33 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
24K
|
11M
|
33
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
waynesworld
|
24K |
11M |
47 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
24K
|
11M
|
47
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
waynesworld
|
24K |
11M |
29 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
24K
|
11M
|
29
|
|
ASX - By Stock
|
IMU |
Re:
Ann: AGM Presentation
|
|
waynesworld
|
217 |
106K |
58 |
04/12/23 |
04/12/23 |
ASX - By Stock
|
217
|
106K
|
58
|
|
ASX - By Stock
|
IMU |
Re:
Ann: AGM Presentation
|
|
waynesworld
|
217 |
106K |
45 |
02/12/23 |
02/12/23 |
ASX - By Stock
|
217
|
106K
|
45
|
|
ASX - By Stock
|
IMU |
Re:
Ann: AGM Presentation
|
|
waynesworld
|
217 |
106K |
51 |
02/12/23 |
02/12/23 |
ASX - By Stock
|
217
|
106K
|
51
|
|
ASX - By Stock
|
IMU |
Re:
Ann: AGM Presentation
|
|
waynesworld
|
217 |
106K |
34 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
217
|
106K
|
34
|
|
ASX - By Stock
|
IMU |
Re:
Ann: AGM Presentation
|
|
waynesworld
|
217 |
106K |
58 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
217
|
106K
|
58
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Polycystic Kidney Disease Program Presentation
|
|
waynesworld
|
10 |
5.1K |
24 |
20/11/23 |
20/11/23 |
ASX - By Stock
|
10
|
5.1K
|
24
|
|
ASX - By Stock
|
PER |
Re:
Ann: Publication of final Long COVID data for ATL1102
|
|
waynesworld
|
8 |
3.5K |
20 |
01/10/23 |
01/10/23 |
ASX - By Stock
|
8
|
3.5K
|
20
|
|
ASX - By Stock
|
PER |
Re:
Ann: Positive Data for ATL1102 in Limb Girdle Muscular Dystrophy
|
|
waynesworld
|
65 |
16K |
19 |
27/09/23 |
27/09/23 |
ASX - By Stock
|
65
|
16K
|
19
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
waynesworld
|
3.5K |
1.0M |
13 |
17/09/23 |
17/09/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
13
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
waynesworld
|
3.5K |
1.0M |
30 |
17/09/23 |
17/09/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
30
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
waynesworld
|
3.5K |
1.0M |
24 |
15/09/23 |
15/09/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
24
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
waynesworld
|
3.5K |
1.0M |
16 |
13/09/23 |
13/09/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
16
|
|
ASX - By Stock
|
PER |
Re:
Ann: Antisense Therapeutics Corporate Presentation
|
|
waynesworld
|
82 |
23K |
13 |
12/09/23 |
12/09/23 |
ASX - By Stock
|
82
|
23K
|
13
|
|
ASX - By Stock
|
PER |
Re:
Ann: Antisense Therapeutics Corporate Presentation
|
|
waynesworld
|
82 |
23K |
30 |
02/09/23 |
02/09/23 |
ASX - By Stock
|
82
|
23K
|
30
|
|